118
Views
0
CrossRef citations to date
0
Altmetric
CLINICAL RESEARCH

Ultrastructural and clinical features of central nervous system melanoma:Analysis of nine cases

, , , , &
Pages 79-89 | Received 01 Dec 2020, Accepted 06 Jan 2021, Published online: 15 Feb 2021

References

  • Zhu W, Zou B, Wang S. Clinicopathological features and prognosis of sinonasal mucosal malignant melanoma: a retrospective study of 83 cases in a Chinese populationORL. J Otorhinolaryngol Relat Spec. 2016;78(2):94–104. doi:10.1159/000444500.
  • Busam KJ. Histopathologic diagnosis of melanoma. Pathology of Melanocytic Tumors. 2019;11:131–139.
  • Brat DJ, Perry A, DN L, et al. Melanocytic lesions. WHO Classification of Tumours of the Central Nervous System Lyon: IARC. 2007.
  • Sarmast AH, Mujtaba B, Bhat AR, et al. A unique case of primary intracranial melanoma. Asian J Neurosurg. 2018;13(1):168–171. doi:10.4103/1793-5482.224832.
  • MacKie RM, Hauschild A, Eggermont AMM. Hauschild A and Eggermont AM. Epidemiology of invasive cutaneous melanoma. Ann Oncol. 2019;20:1–7. doi:10.1093/annonc/mdp252.
  • Ali Z, Yousaf N, Larkin J. Yousaf N and Larkin J. Melanoma epidemiology, biology and prognosis. EJC Suppl. 2013;11(2):81–91. doi:10.1016/j.ejcsup.2013.07.012.
  • Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. doi:10.1002/ijc.29210.
  • Rastrelli M, Tropea S, Rossi CR, et al. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classifcation. In Vivo. 2014;28(6):1005–1011.
  • Duncan LM. The classification of cutaneous melanoma. Hematol Oncol Clin North Am. 2009;23(3):501–513. doi:10.1016/j.hoc.2009.03.013.
  • Meyle KD, Guldberg P. Genetic risk factors for melanoma. Hum Genet. 2009;4(4):499–510. doi:10.1007/s00439-009-0715-9.
  • Markovic SN, Erickson LA, Rao RD, et al. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc. 2007;3:364–380.
  • Montone KT. The differential diagnosis of sinonasal/nasopharyngeal neuroendocrine/neuroectodermally derived tumors. Arch Pathol Lab Med. 2015;139(12):1498–1507. doi:10.5858/arpa.2014-0383-RA.
  • Tas F, Keskin S, Karadeniz A, et al. Noncutaneous melanoma have distinct features from each other and cutaneous melanoma. Oncology. 2011;81(5–6):353–358. doi:10.1159/000334863.
  • Han KJ, Il LS, Hyoung LD, et al. Noncutaneous malignant melanoma: a prognostic model from a retrospective multicenter study. BMC Cancer. 2010;10(1):167. doi:10.1186/1471-2407-10-167.
  • Wang ZC. Neurosurgery. Wuhan: Hubei Science and Technology Press; 1998:570–571.
  • Huang WQ. Nerve Tumor Pathology. Shanghai: ShanghaiScience and Technology Press; 1982:209–212.
  • Vanea E, Charlier N, Dewever J, et al. Molecular electron paramagnetic resonance imaging of melanin in melanomas: a proof-of-concept. NMR Biomed. 2008;21(3):296–300. doi:10.1002/nbm.1241.
  • Nakagawa K, Minakawa S, Sawamura D. Nondestructive evaluations of melanin-related compounds in the skin using permeability and electron paramagnetic resonance. Analytical Sciences. 2020;36(7):865–869. doi:10.2116/analsci.20P001.
  • Mignion L, Karroum O, Karroum O, et al. Influence of paramagnetic melanin on the MRI contrast in melanoma: a combined high-field (11.7 T) MRI and EPR study. Contrast Media Mol Imaging. 2014;9(2):154–160. doi:10.1002/cmmi.1554.
  • Peydró-Olaya A, Llombart-Bosch A, Carda-Batalla C, et al. Electron microscopy and other ancillary techniques in the diagnosis of small round cell tumors. Semin Diagn Pathol. 2003;20(1):25–45.
  • Rossouw DJ, Cinti S, Dickersin GR. Liposarcoma: an ultrastructural study of 15 cases. Am J Clin Pathol. 1986;85(6):649–667. doi:10.1093/ajcp/85.6.649.
  • Rubinstein LJ.Neurocutaneous melanosis and primary meningeal melanoma. In: Tumours of the Central Nervous System. Atlas of Tumor Pathology, Steven G. Silverberg (Ed.), 2nd Series, Fasc.6. Washington, DC: Armed Forces Institute of Pathology; 1972:309–311
  • Willis RA. Pathology of Tumor. London: Buttereorths; 1967:930.
  • Suranagi VV, Maste P, Malur PR. Primary intracranial malignant melanoma. A Rare Case with Review of Literature Asian Journal of Neurosurgery. 2015;10(1):39–41. doi:10.4103/1793-5482.151508.
  • Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97–109. doi:10.1007/s00401-007-0243-4.
  • Sakata K, Miyoshi J, Takeshige N, et al. Primary meningeal melanocytoma of the sellar region: review of the literature and differential diagnosis with special reference to angiographical features. Pituitary. 2015;18(5):685–694. doi:10.1007/s11102-015-0635-8.
  • Lee NK, Lee JY, Wang KC, et al. Primary atypical melanocytoma arising from the cavernous sinus in a child. Childs Nervous System. 2015;31(9):1577–1582. doi:10.1007/s00381-015-2741-3.
  • Shinsato Y, Hanada T, Kisanuki T, et al. Primary malignant melanoma in the pineal region treated without chemotherapy. Surg Neurol Int. 2012;3(1):123. doi:10.4103/2152-7806.102348.
  • Ma J, Zhang Z, Li S, et al. Intracranial amelanotic melanoma: a case report with literature review. World J Surg Oncol. 2015;13(1):182. doi:10.1186/s12957-015-0600-z.
  • Piercecchi-Marti MD, Mohamed H, Liprandi A, et al. Intracranial meningeal melanocytoma associated with ipsilateral nevus of Ota: case report. J Neurosurg. 2002;96(3):619–623. doi:10.3171/jns.2002.96.3.0619.
  • Wu C, Wang H, Li NY, et al. CNS melanoma 10 cases of clinical pathology and ultrastructure of analysis. Diagnostic Pathology J. 2010;17(4):245–248.
  • Rades D, Schild SE, Tatagiba M, et al. Therapy of meningeal melanocytomas. Cancer. 2004;100(11):2442–2447. doi:10.1002/cncr.20296.
  • Bowman SL, Bi-Karchin J, Le L, et al. The road to lysosome-related organelles: insights from Hermansky-Pudlak syndrome and other rare diseases. Traffic. 2019;20:404–435.
  • Ghadially FN. Melanosomes in Book: Ultrastructural Pathology of the Cell and Matrix. Woburn: Butterworth Publishers; Vol. 2. Third Edition ed. 1988:787–826.
  • Eyden B. Organelles in Tumor Diagnosis: An Ultrastructural Atlas. New York, Tokyo: Igaku-Shoin; 1996.
  • Hurbain I, Geerts WJC, Boudier T, et al. Electron tomography of early melanosomes: implications for melanogenesis and the generation of fibrillar amyloid sheets. Proceedings of the National Academy of Sciences of the United States of America, 2008 105( 50):19726–19731
  • Slominski A, Tobin DJ, Shibahara S, et al. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev. 2004;84(4):1155–1228.
  • Raposo G, Tenza D, Murphy DM, et al. Distinct protein sorting and localization to premelanosomes, melanosomes, and lysosomes in pigmented melanocytic cells. J Cell Biol. 2001;152(4):809–824. doi:10.1083/jcb.152.4.809.
  • Setaluri V. The melanosome: dark pigment granule shines bright light on vesicle biogenesis and more. J Invest Dermatol. 2003;121(4):650–660. doi:10.1046/j.1523-1747.2003.12500.x.
  • Hearing VJ. Biogenesis of pigment granules: a sensitive way to regulate melanocyte function. J Dermatol Sci. 2005;37(1):3–14. doi:10.1016/j.jdermsci.2004.08.014.
  • D’Ischia M, Wakamatsu K, Cicoira F, et al. Melanins and melanogenesis: from pigment cells to human health and technological applications. Pigment Cell Melanoma Res. 2015;28(5):520–544.
  • Wilms H, Rosenstiel P, Sievers J, et al. Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson’s disease. Faseb J. 2003;17(3):500–502. doi:10.1096/fj.02-0314fje.
  • Zecca L, Bellei C, Costi P, et al. New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals. Proc Natl Acad Sci USA. 2008a;105(45):17567–17572. doi:10.1073/pnas.0808768105.
  • Zecca L, Casella L, Albertini A, et al. Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson’s disease. J Neurochem. 2008b;106(4):1866–1875.
  • Zecca L, Wilms H, Geick S, et al. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson’s disease. Acta Neuropathol. 2008c;116(1):47–55.
  • H Y P, Kosmadaki M, Yaar M, et al. Cellular mechanisms regulating human melanogenesis. Cellular & Molecular Life Sciences. 2009;66(9):1493–1506.
  • Oruckaptan HH, Soylemezoglu F, Kutluk T, et al. Benign melanocytic tumor in infancy: discussion on a rare case and review of the literature. Pediatr Neurosurg. 2000;32(5):240–247.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.